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INTRODUCTION
Members of the genus Rickettsia are commonly
associated with haematophagous arthropods such
as ticks, ﬂeas or lice. Rickettsia felis is a bacterium
belonging to the spotted fever group of the genus
Rickettsia.
It was ﬁrst detected by Adams et al. in 1990 [1]
in the midgut cells of a cat ﬂea (Ctenocephalides
felis), and was later described as a new Rickettsia
species [2]. This organism was found, by molec-
ular assays, to infect ﬂeas in different parts of the
world, suggesting a cosmopolitan distribution.
R. felis is maintained in the cat ﬂea by transovar-
ian transmission. Infection in humans has been
reported in the USA, Mexico, Brazil, France and
Spain [3].
The present study used PCR and DNA
sequencing to evaluate the presence of R. felis
infection in ﬂeas from Italy, where the distribu-
tion of this agent is still unknown.
MATERIALS AND METHODS
Collection of ﬂeas started in October 2007, in north-eastern
Italy. To date, 29 Ctenocephalides felis ﬂeas from dogs and cats
from Padova (n = 22) and Verona (n = 7) municipalities,
Veneto region, have been subjected to preliminary examina-
tion.
DNA extraction was performed using the guanidine thio-
cyanate protocol.
For this purpose, each ﬂea was placed in a 1.5-mL
microtube containing 150 lL of TE buffer (Tris-HCl
10 mmol ⁄L, EDTA 1 mmol ⁄L, pH 7.4) and homogenized by
using a sterile micropestle. Next, 450 lL of guanidine thiocy-
anate (5 mol ⁄L) was added to the tube, which was vortexed
again and incubated for 10 min at room temperature with
short vortexing every 2 min. Thereafter, 100 lL of chloroform
was added to the tube. The tube was centrifuged at 12 000 g
for 5 min to separate the aqueous phase, which was trans-
ferred to a clean 1.5-mL microtube. Next, 600 lL of isopropa-
nol was added to the aqueous phase (400 lL), which was
homogenized by inverting the tube several times and then
incubated at )20C overnight. Thereafter, the tube was
centrifuged at 12 000 g for 15 min; the supernatant was
discarded, and the pellet was dried at room temperature and
then resuspended in 30 lL of buffer TE. Finally, the microtu-
bes were incubated at 56C for 15 min to facilitate DNA
homogenization, and then stored at )20C until being tested
by PCR.
Five microlitres of extracted DNA of the ﬂea were used for
ampliﬁcation of a 401-bp fragment of the rickettsial gltA gene
(citrate synthase gene) by a routine PCR with primers CS-78
(forward) and CS-323 (reverse) [4].
PCRs (25 lL) were performed in an Applied Biosystems
Thermocycler (Gene Amp PCR System 2700) by adding 5 lL of
the DNA template to 12.5 lL of the PCR iQSupermix, 1.0 lL of
each primer at 20 lM, and 5.5 lL of molecular-grade water.
For each reaction, a negative control (water) and a positive
control were included. Ten microlitres of the PCR product
were separated by electrophoresis in a 1.5% agarose gel,
stained with ethidium bromide, and examined by UV trans-
illumination.
PCR products of the expected sizes were cloned by using
the TOPO TA Cloning kit (Invitrogen, Carlsbad, CA, USA).
Plasmids containing the DNA inserts of the expected sizes
were sequenced at least four times by using an ABI automated
sequencer with M13 forward and M13 reverse sequencing
primers (Invitrogen).
RESULTS
In total, nine ﬂeas (31.0%), six from dogs from
Padova and three from cats from Verona, yielded
expected bands by PCR, which were all demon-
strated by DNA sequencing to be identical to each
other and to the corresponding sequence of the
gltA gene of R. felis deposited in GenBank
(Table 1).
Table 1. Fleas found to be positive by PCR and sequenc-






felis from catsa Totala
Padova 6 ⁄ 20 (30.0) 0 ⁄ 2 (0) 6 ⁄ 22 (27.3)
Verona 0 ⁄ 0 (0) 3 ⁄ 7 (42.9) 3 ⁄ 7 (42.9)
Total 6 ⁄ 20 (30.0) 3 ⁄ 9 (33.3) 9 ⁄ 29 (31.0%)
aNumber of positive ﬂeas ⁄number of tested ﬂeas (%).
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CONCLUSIONS
This study represents the ﬁrst report of natural
infection with R. felis in ﬂeas from dogs and cats
of Italy. We started to collect ﬂeas in north-eastern
Italy, but it is necessary to increase the study area,
because the apparently high infection rate re-
corded could be biased by the small sample size,
and needs to be conﬁrmed by further studies.
However, 15% of ﬂeas were estimated to be
infected in France [5].
The role of mammals, including dogs and cats,
in the epidemiology of ﬂea-borne spotted fever is
yet to be determined.
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